VSIR and renal cell carcinoma: For example, in patients with melanoma, any level of VISTA expression in the tumor-infiltrating inflammatory cells of their primary melanoma decreased survival, whereas in renal cell carcinoma (RCC), VISTA-positive immune cells homing to the venous tumor thrombus, but not to the primary RCC itself, indicated poor prognosis (29, 40).